As of August 24, 2016, the Access to Cannabis for Medical Purposes Regulations (ACMPR) has replaced the Marihuana for Medical Purposes Regulations (MMPR). With our updated licence, Labs-Mart proudly continues to offer our full range of testing services for licensed producers as well as registered individuals and designated producers. All our methods are validated and follow established protocols published by Health Canada or United States Pharmacopoeia (USP).

ACMPR Required Testing

  • THC & CBD content
  • Microbial contamination
  • Heavy metal contamination
  • Pesticide contamination
  • Solvent contamination [Class I & II solvents] (cannabis oil only)
  • Disintegration testing (cannabis oil capsules only)

Quality Control Testing (Not Required by ACMPR)

  • Cannabinoid profiling
  • Terpene content
  • Genetic identification
  • GMO testing
  • Nutritional information (cannabis oil only)
  • Rancidity testing (cannabis oil only)
  • Stability testing (cannabis oil and capsules only)

Package pricing and volume discounts available! Labs-Mart continues to offer free technical consultation to licensed producers, so call us today and let us make ACMPR compliance easy for you!

Cannabinoid Profiling

The following is a list of key analytes for cannabis testing. Chromatographic system for quantification can be HPLC-UV, LC-MS, or GC-FID depending on compound concentration and stability.

Group Chemical Name Chemical Structure Notes
Major Cannabinoids Δ9-Tetrahydrocannabinol (Δ9-THC) Delta-9-tetrahydrocannabinol Prevalent in “drug-type” cannabis, psychoactive
Cannabidiol (CBD) Cannabidiol Prevalent in “fibre-type” cannabis, non-psychoactive
Cannabinoid Acids Tetrahydrocannabinolic acid (THCA) Tetrahydrocannabinolic Acid Predominant naturally-occurring form of THC, non-psychoactive
Cannabidiolic acid (CBDA) Cannabidiolic Acid Predominant naturally-occurring form of CBD, non-psychoactive
Cannabigerolic acid (CBGA) Cannabigerolic Acid A Direct precursor to THCA and CBDA, non-psychoactive
Minor Cannabinoids Tetrahydrocannabivarin (THCV) Tetrahydrocannabivarin THC analogue with altered effects, non-psychoactive
Cannabinol (CBN) Cannabinol Product of THC oxidation, approximately 10% as psychoactive
Cannabigerol (CBG) Cannabigerol Precursor product of other cannabinoids, non-psychoactive
Cannabielsoin (CBE) Cannabielsoin Found in processed cannabis, such as hashish
Cannabitriol (CBT) Type (-)-trans-Cannabitriol Found in cannabis pollen
Cannabichromene (CBC) Type Cannabichromene Found in juvenile plants, non-psychoactive
Other Compounds of Interest Terpenoids Group of compounds found in the essential oil of cannabis, responsible for its distinctive odour
Flavones Group of compounds that may act as phytoestrogens

 

References

Health Canada. Access to Cannabis for Medical Purposes Regulations. August 2016.

Health Canada. Licensed dealer testing of cannabis produced by individuals. August 2016.

Health Canada. Understanding the New Access to Cannabis for Medical Purposes Regulations. August 2016.

Government of Canada. Food and Drug Act. 1985.